Establishment of a cell-based 2009 H1N1 influenza neuraminidase inhibitors evaluation system

Yaoxue Xuebao

Volumn 45, Issue 3, 2010, Pages 383-387

  Zhang, Chao ^a   Cao, Ying Li ^a   Zhong, Wu ^b   Xiao, Jun Hai ^b   Guo, Ying ^a,b  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

H1N1; Neuraminidase inhibitor; Oseltamivir resistance; Pseudotyping virus

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; HEMAGGLUTININ; OSELTAMIVIR; SIALIC ACID; SIALIDASE; SIALIDASE INHIBITOR; VIRUS PROTEIN; ZANAMIVIR;

ARTICLE; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS 1; IC 50; INFLUENZA VIRUS A H1N1; POINT MUTATION; VIRUS PARTICLE;

CELL LINE, TUMOR; DRUG RESISTANCE, VIRAL; ENZYME INHIBITORS; HEK293 CELLS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HIV-1; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; MUTATION; NEURAMINIDASE; OSELTAMIVIR; PLASMIDS; TRANSFECTION; VIRUS INTERNALIZATION;

EID: 77952158800     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Influenza. WHO fact sheet No.211 revised March 2003 [R]. http://www.who.int/mediacentre/factsheets/2003/fs211/en/.
2. Swine influenza A(H1N1) infection in two children - southern California, March-April, 2009 [R]. MMWR, 2009:400-402.
3. http://www.moh.gov.cn/publicfiles/business/htmlfiles/wsb/pyqxx/list.htm.
4. Options for use of antivirals for influenza A (H1N1) cases. http://www.wpro.who.int/NR/rdonlyres/7D1FC5E7-828C-412A-BBB2-D40FB97CAE49/0/ antivirals.pdf.
5. Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis - North Carolina, 2009 [R]. MMWR, 2009,58:969-972.
6. Chen H, Cheung CL, Yuen KY, et al. Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China [J]. Emerg Infect Dis, 2009,15:1970-1972.
7. Potier M, Mameli L, Melançon SB, et al. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-D-N-acetylneuraminate) substrate [J]. Anal Biochem, 1979,94:287-296. (Pubitemid 9173017)
8. Buxton RC, Edwards B, Bethell RC, et al. Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir [J]. Anal Biochem, 2000,280:291-300. (Pubitemid 30308085)
9. Cabezas JA, Reglero A, Hannoun C. A fluorometric procedure for measuring the neuraminidase activity: its application to the determination of this activity in influenza and parainfluenza viruses [J]. Anal Biochem, 1983,131:121-126. (Pubitemid 13058985)
10. Palese P, Tobita K, Compans RW, et al. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase [J]. Virology, 1974,61:397-410.
11. Collins PJ, Haire LF, Hay AJ, et al. Structural basis for oseltamivir resistance of influenza viruses [J]. Vaccine, 2009,27:6317-6323.
12. Guo Y, Rumschlag-Booms E, Rong LJ, et al. Analysis of hemagglutinin-mediated entry tropism of H5N1 avian influenza [J]. Virol J, 2009,6:1-13.
13. Rumschlag-Booms E, Guo Y, Rong LJ, et al. Comparative analysis between a low pathogenic and a high pathogenic influenza H5 hemagglutinin in cell entry [J]. Virol J, 2009,6:76.
14. Guo Y, Yu X, Rong LJ, et al. The role of a conserved acidic residue in calcium-dependent protein folding for a low density lipoprotein (LDL)-A module [J]. J Biol Chem, 2004,279:16629-16637.
15. Cao YL, Li SX, Guo Y, et al. Establishment of pharmacological evaluation system for non-nucleoside reverse-transcriptase inhibitors resistant HIV-1 [J]. Acta Pharm Sin, 2009,44:355-361.
16. Wagner R, Matrosovich M, Klenk HD. Functional balance between haemagglutinin and neuraminidase in influenza virus infections [J]. Rev Med Virol, 2002,12:159-166. (Pubitemid 34516947)
17. Song G, Yang S, Guo Y, et al. Discovery of the first series of small molecule H5N1 entry inhibitors [J]. J Med Chem, 2009,52:7368-7371.